ScreenerHero

BIOG-B BioGaia AB (publ)

STO · SE · Healthcare · Drug Manufacturers - Specialty & Generic · biogaiagroup.com
114.20SEK+0.18%Mkt Cap: 1.10B $P/E: 33.24

BioGaia AB (publ), a healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, a…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
Merck KGaA
$64.30BUSDP/E 25.0
TAK
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)
$57.06BUSD
TEVA
Teva Pharmaceutical Industries Limited Ordinary Shares
$46.10BUSDP/E 65.9
HLN
Haleon plc American Depositary Shares (Each representing two Ordinary Shares)
$38.70BUSDP/E 18.3
ZOE
Zoetis Inc.
$28.27BUSDP/E 12.1
ZTS
Zoetis Inc. Class A Common Stock
$28.80BUSDP/E 11.4
UTHR
United Therapeutics Corporation - Common Stock
$23.23BUSDP/E 19.4
VTRS
Viatris Inc. - Common Stock
$20.22BUSD
SOBI
Swedish Orphan Biovitrum AB
$14.24BUSDP/E 109.4
NBIX
Neurocrine Biosciences, Inc. - Common Stock
$14.55BUSDP/E 21.0
IPN
Ipsen S.A.
$12.60BUSDP/E 22.8
ELAN
Elanco Animal Health Incorporated Common Stock
$11.06BUSD
RDY
Dr. Reddy's Laboratories Ltd Common Stock
$10.20BUSDP/E 29.2
KRK
Krka, d. d.
$8.50BUSDP/E 18.4
AMRX
Amneal Pharmaceuticals, Inc. - Class A Common Stock
$7.07BUSDP/E 42.3
ALKS
Alkermes plc - Ordinary Shares
$7.00BUSDP/E 109.9
HIMS
Hims & Hers Health, Inc. Class A Common Stock
$6.77BUSD
LNTH
Lantheus Holdings, Inc. - Common Stock
$6.53BUSDP/E 23.9
KNSA
Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares
$5.83BUSDP/E 76.6
INDV
Indivior Pharmaceuticals, Inc. - Common Stock
$4.21BUSDP/E 12.8

Key Statistics

Company
Market Cap1.10B USD
Enterprise Value1.06B USD
Revenue (TTM)151.19M USD
Gross Profit107.95M USD
Net Income (TTM)31.83M USD
Revenue/Share15.63 SEK
Last Price114.20 SEK
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees251
CountrySE
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)33.24
P/E (Forward)26.33
PEG—
EV/EBITDA24.39
EV/Revenue7.01
P/S7.30
P/B10.47
EPS (TTM)3.43
EPS (Forward)4.33
52W Range
96.2045% of range136.30
52W High136.30 SEK
52W Low96.20 SEK
Profitability
Gross Margin73.37%
Oper. Margin28.39%
EBITDA Margin28.76%
Profit Margin21.63%
ROE25.32%
ROA20.83%
Growth
Revenue Growth8.90%
Earnings Growth17.40%
Cash Flow & Leverage
Operating CF29.32M USD
CapEx (TTM)344.25K USD
FCF Margin14.46%
FCF Yield1.98%
Net Debt-42.69M USD
Net Debt/EBITDA-0.98
Balance Sheet
Debt/Equity—
Current Ratio4.44
Quick Ratio2.11
Book Value/Sh10.88 SEK
Cash/Share4.41 SEK
Dividends
Fwd Div Rate1.64 SEK
Trail. Div Rate1.64 SEK
Div. Yield1.44%
5Y Avg Yield1.14%
Payout Ratio47.81%
Ex-Div DateMay 8, 2026
Pay Date—
Splits
Last Split5:1
Split DateMay 18, 2022
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)155.50 SEK
Upside (mean)+36.2%
Target Range146.00 SEK – 165.00 SEK
146.00+36.2% to mean165.00
# Analysts2
Ownership
Shares Out.98.50M
Float83.94M
Insiders17.00%
Institutions52.16%
Technical
SMA 50112.96 (+1.1%)
SMA 200115.42 (-1.1%)
Beta0.32
S&P 52W Chg14.58%
Avg Vol (30d)171.79K
Avg Vol (10d)167.86K
Technical Indicators
RSI (14)54.5
MACD0.4573
MACD Signal-0.2729
MACD Hist.+0.7302
BB Upper117.01 SEK
BB Middle110.94 SEK
BB Lower104.87 SEK
BB Width10.93%
ATR (14)2.662 SEK
Vol Ratio (20d)0.62x